Determinants of direct medical costs in primary and revision total knee arthroplasty knee

Clinical Orthopaedics and Related Research

Volumn 471, Issue 1, 2013, Pages 206-214

  Maradit Kremers, Hilal ^a,b   Visscher, Sue L ^a   Moriarty, James P ^a   Reinalda, Megan S ^a   Kremers, Walter K ^a   Naessens, James M ^a   Lewallen, David G ^b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FRACTURE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; JOINT INSTABILITY; KNEE PROSTHESIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATING ROOM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS FRACTURE; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; TOTAL KNEE REPLACEMENT; TREATMENT INDICATION; UNITED STATES; VASCULAR DISEASE;

EID: 84871613777     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-012-2508-z     Document Type: Conference Paper

References (41)

1. Agency for Healthcare Research and Quality. Procedures with the Most Rapidly Increasing Hospital Costs, 2004-2007. HCUP Statistical Brief #82. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
2. American Academy of Orthopaedic Surgeons. United States Bone and Joint Decade: The Burden of Musculoskeletal Diseases in the United States: Prevalence, Societal and Economic Cost. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2008.
3. Centers for Medicare & Medicaid Services. Berenson-Eggers Type of Service (BETOS) codes. 2011. Available at: https://www.cms.gov/ HCPCSReleaseCodeSets/20-BETOS.asp. Accessed December 5, 2011.
4. Baser O, Supina D, Sengupta N, Wang L, Kwong L. Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery. Curr Med Res Opin. 2011;27:423429.
5. Berry DJ, Kessler M, Morrey BF. Maintaining a hip registry for 25 years: Mayo Clinic experience. Clin Orthop Relat Res. 1997;344:61-68.
6. Berry DJ, von Knoch M, Schleck CD, Harmsen WS. Effect of femoral head diameter and operative approach on risk of dislocation after primary total hip arthroplasty. J Bone Joint Surg Am. 2005;87:2456-2463.
7. Bozic KJ, Morshed S, Silverstein MD, Rubash HE, Kahn JG. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am. 2006;88:706-714.
8. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746-1751.
9. Davenport DL, Henderson WG, Khuri SF, Mentzer RM Jr. Preoperative risk factors and surgical complexity are more predictive of costs than postoperative complications: a case study using the National Surgical Quality Improvement Program (NSQIP) database. Ann Surg. 2005;242:463-468; discussion 468-471.
10. Dreghorn CR, Roughneen P, Graham J, Hamblen DL. The real cost of joint replacement. Br Med J (Clin Res Ed). 1986;292:1636-1637.
11. Dummit LA. Medicare's bundling pilot: including post-acute care services. Issue Brief Natl Health Policy Forum. 2011;841:1-23.
12. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
13. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102-109.
14. Gioe TJ, Sharma A, Tatman P, Mehle S. Do "premium" joint implants add value? Analysis of high cost joint implants in a community registry. Clin Orthop Relat Res. 2011;469:48-54.
15. Hawker GA, Badley EM, Croxford R, Coyte PC, Glazier RH, Guan J, Harvey BJ, Williams JI, Wright JG. A population-based nested case-control study of the costs of hip and knee replacement surgery. Med Care. 2009;47:732-741.
16. Healy WL, Finn D. The hospital cost and the cost of the implant for total knee arthroplasty: a comparison between 1983 and 1991 for one hospital. J Bone Joint Surg Am. 1994;76:801-806.
17. Hebert CK, Williams RE, Levy RS, Barrack RL. Cost of treating an infected total knee replacement. Clin Orthop Relat Res. 1996;331:140-145.
18. Hellmann M, Mehta SD, Bishai DM, Mears SC, Zenilman JM. The estimated magnitude and direct hospital costs of prosthetic joint infections in the United States, 1997 to 2004. J Arthroplasty. 2010;25:766-771.e1.
19. Huddleston JM, Long KH, Naessens JM, Vanness D, Larson D, Trousdale R, Plevak M, Cabanela M, Ilstrup D, Wachter RM. Medical and surgical comanagement after elective hip and knee arthroplasty: a randomized, controlled trial. Ann Intern Med. 2004;141:28-38.
20. Kelly MP, Bozic KJ. Cost drivers in total hip arthroplasty: effects of procedure volume and implant selling price. Am J Orthop. 2009;38:E1-E4.
21. Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004. Arthritis Rheum. 2008;59:481-488.
22. Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res. 2010;96:124-132.
23. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785.
24. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467:2606-2612.
25. Lavernia C, Lee DJ, Hernandez VH. The increasing financial burden of knee revision surgery in the United States. Clin Orthop Relat Res. 2006;446:221-226.
26. Lavernia CJ, D'Apuzzo MR, Hernandez VH, Lee DJ, Rossi MD. Postdischarge costs in arthroplasty surgery. J Arthroplasty. 2006;21:144-150.
27. Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001;285:60-66.
28. Losina E, Thornhill TS, Rome BN, Wright J, Katz JN. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am. 2012;94:201-207.
29. Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med. 2009;169:1113-1121; discussion 1121-1112.
30. March L, Cross M, Tribe K, Lapsley H, Courtenay B, Brooks P. Cost of joint replacement surgery for osteoarthritis: the patients' perspective. J Rheumatol. 2002;29:1006-1014.
31. Meyers SJ, Reuben JD, Cox DD, Watson M. Inpatient cost of primary total joint arthroplasty. J Arthroplasty. 1996;11:281-285.
32. Oduwole KO, Molony DC, Walls RJ, Bashir SP, Mulhall KJ. Increasing financial burden of revision total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2010;18:945-948.
33. Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplasty. 2010;25:103-107.
34. Reuben JD, Meyers SJ, Cox DD, Elliott M, Watson M, Shim SD. Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty. 1998;13:172-179.
35. Shwartz M, Iezzoni LI, Moskowitz MA, Ash AS, Sawitz E. The importance of comorbidities in explaining differences in patient costs. Med Care. 1996;34:767-782.
36. Slover J, Espehaug B, Havelin LI, Engesaeter LB, Furnes O, Tomek I, Tosteson A. Cost-effectiveness of unicompartmental and total knee arthroplasty in elderly low-demand patients: a Markov decision analysis. J Bone Joint Surg Am. 2006;88:2348-2355.
37. Sood N, Huckfeldt PJ, Escarce JJ, Grabowski DC, Newhouse JP. Medicare's bundled payment pilot for acute and postacute care: analysis and recommendations on where to begin. Health Aff (Millwood). 2011;30:1708-1717.
38. Stargardt T. Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries. Health Econ. 2008;17:S9-S20.
39. Vekeman F, LaMori JC, Laliberte F, Nutescu E, Duh MS, Bookhart BK, Schein J, Dea K, Olson WH, Lefebvre P. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population. J Med Econ. 2011;14:324-334.
40. Wei MH, Lin YL, Shi HY, Chiu HC. Effects of provider patient volume and comorbidity on clinical and economic outcomes for total knee arthroplasty: a population-based study. J Arthroplasty. 2010;25:906-912.e1.
41. Wilson NA, Schneller ES, Montgomery K, Bozic KJ. Hip and knee implants: current trends and policy considerations. Health Aff (Millwood). 2008;27:1587-1598.